A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma
Andrew W. Hahn, Charles Drake, Samuel R. Denmeade, Yousef Zakharia, Benjamin L. Maughan, Eugene Kennedy, Charles Link, Nicholas Vahanian, Hans Hammers, Neeraj Agarwal
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 August 2020.
All research outputs
#2,259,902
of 34,200,840 outputs
Outputs from Oncologist
#449
of 4,853 outputs
Outputs of similar age
#35,547
of 380,191 outputs
Outputs of similar age from Oncologist
#12
of 81 outputs
Altmetric has tracked 34,200,840 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,853 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 380,191 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.
